text_1: B3-Galectin increases cell resistance to tyrosine kinase inhibitors (TKIs) by engaging the alternate KRAS-RalB signaling complex downstream of EGFR.
text_2: Tumour cells, with stem-like properties, are highly aggressive and often show drug resistance.